PFE Share Price

Open 31.54 Change Price %
High 31.73 1 Day 0.17 0.54
Low 31.36 1 Week -0.06 -0.19
Close 31.63 1 Month 1.74 5.82
Volume 18975665 1 Year -0.76 -2.35
52 Week High 37.39
52 Week Low 28.25
PFE Important Levels
Resistance 2 31.97
Resistance 1 31.83
Pivot 31.57
Support 1 31.43
Support 2 31.29
NYSE USA Most Active Stocks
BAC 21.23 -1.26%
BAC 21.23 -1.26%
BAC 21.23 -1.26%
EMC 29.05 0.97%
EMC 29.05 0.97%
EMC 29.05 0.97%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
WSH 47.18 -2.86%
More..
NYSE USA Top Gainers Stocks
POM 26.93 26.79%
POM 26.93 26.79%
CAS 0.51 24.39%
CAS 0.51 24.39%
CAS 0.51 24.39%
CAS 0.51 24.39%
CAS 0.51 24.39%
VNR 0.91 19.74%
VNR 0.91 19.74%
P 13.33 16.11%
More..
NYSE USA Top Losers Stocks
ENL 15.81 -66.25%
ENL 15.81 -66.25%
ENL 15.81 -66.25%
OIBR 0.17 -43.33%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
More..

Pfizer, Inc. (NYSE: PFE)

PFE Technical Analysis 3
As on 2nd Dec 2016 PFE Share Price closed @ 31.63 and we RECOMMEND Sell for LONG-TERM with Stoploss of 32.86 & Sell for SHORT-TERM with Stoploss of 32.48 we also expect STOCK to react on Following IMPORTANT LEVELS.
PFE Target for December
1st Target up-side 34.32
2nd Target up-side 35.85
3rd Target up-side 37.38
1st Target down-side 29.96
2nd Target down-side 28.43
3rd Target down-side 26.9
PFE Other Details
Segment EQ
Market Capital 99999997952.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.pfizer.com
PFE Address
PFE
235 East 42nd Street
New York, NY 10017
United States
Phone: 212-733-2323
Interactive Technical Analysis Chart Pfizer, Inc. ( PFE NYSE USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Pfizer, Inc.
PFE Business Profile
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells healthcare products worldwide. Its product portfolio includes medicines and vaccines, as well as various consumer healthcare products. The company’s Primary Care segment offers prescription pharmaceutical products primarily prescribed by primary-care physicians for various therapeutic and disease areas comprising Alzheimer’s disease, cardiovascular, erectile dysfunction, genitourinary, major depressive disorder, pain, respiratory, and smoking cessation. Its Specialty Care and Oncology segment provides prescription pharmaceutical products for anti-infectives, endocrine disorders, hemophilia, inflammation, ophthalmology, pulmonary arterial hypertension, specialty neuroscience, and vaccines, as well as oncology and oncology-related illnesses. The company’s Established Products and Emerging Markets segment offers prescription pharmaceutical products that had lost patent protection or marketing exclusivity in certain countries and/or regions, as well as sold in emerging markets, including Asia, Latin America, the Middle East, Eastern Europe, Africa, Turkey, and Central Europe. Its Consumer Healthcare segment provides non-prescription products in a range of therapeutic categories, such as dietary supplements, pain management, respiratory, and personal care. The company primarily offers biopharmaceutical products, including Lyrica, the Prevnar family of products, Enbrel, Celebrex, Lipitor, Viagra, Zyvox, Norvasc, Sutent, and the Premarin family of products; and consumer healthcare products under the Advil, Caltrate, Centrum, ChapStick, Emergen-C, Preparation H, and Robitussin brands. It sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, and grocery and convenience stores. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.